Cargando…
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914359/ https://www.ncbi.nlm.nih.gov/pubmed/33664874 http://dx.doi.org/10.7150/thno.58558 |
| _version_ | 1783656984314118144 |
|---|---|
| author | Dong, Jiang-Kai Lei, Hui-Min Liang, Qian Tang, Ya-Bin Zhou, Ye Wang, Yang Zhang, Shengzhe Li, Wen-Bin Tong, Yunguang Zhuang, Guanglei Zhang, Liang Chen, Hong-Zhuan Zhu, Liang Shen, Ying |
| author_facet | Dong, Jiang-Kai Lei, Hui-Min Liang, Qian Tang, Ya-Bin Zhou, Ye Wang, Yang Zhang, Shengzhe Li, Wen-Bin Tong, Yunguang Zhuang, Guanglei Zhang, Liang Chen, Hong-Zhuan Zhu, Liang Shen, Ying |
| author_sort | Dong, Jiang-Kai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7914359 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Ivyspring International Publisher |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79143592021-03-03 Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum Dong, Jiang-Kai Lei, Hui-Min Liang, Qian Tang, Ya-Bin Zhou, Ye Wang, Yang Zhang, Shengzhe Li, Wen-Bin Tong, Yunguang Zhuang, Guanglei Zhang, Liang Chen, Hong-Zhuan Zhu, Liang Shen, Ying Theranostics Erratum Ivyspring International Publisher 2021-02-09 /pmc/articles/PMC7914359/ /pubmed/33664874 http://dx.doi.org/10.7150/thno.58558 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
| spellingShingle | Erratum Dong, Jiang-Kai Lei, Hui-Min Liang, Qian Tang, Ya-Bin Zhou, Ye Wang, Yang Zhang, Shengzhe Li, Wen-Bin Tong, Yunguang Zhuang, Guanglei Zhang, Liang Chen, Hong-Zhuan Zhu, Liang Shen, Ying Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum |
| title | Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum |
| title_full | Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum |
| title_fullStr | Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum |
| title_full_unstemmed | Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum |
| title_short | Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum |
| title_sort | overcoming erlotinib resistance in egfr mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: erratum |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914359/ https://www.ncbi.nlm.nih.gov/pubmed/33664874 http://dx.doi.org/10.7150/thno.58558 |
| work_keys_str_mv | AT dongjiangkai overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT leihuimin overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT liangqian overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT tangyabin overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT zhouye overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT wangyang overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT zhangshengzhe overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT liwenbin overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT tongyunguang overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT zhuangguanglei overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT zhangliang overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT chenhongzhuan overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT zhuliang overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum AT shenying overcomingerlotinibresistanceinegfrmutationpositivelungadenocarcinomasthroughrepressionofphosphoglyceratedehydrogenaseerratum |